54 research outputs found
Antinociceptive effects of acetyl met-enkephalin derivatives following intrathecal administration in rat
Introduction: Intrathecal infusion of some enkephalin derivatives has been shown to restore analgesia in morphine tolerant patients with less adverse effects such as respiratory depression and constipation compared to morphine. Therefore developing new enkephalin derivatives is of central interest in pain management. In this study, antinociceptive effects of intrathecal administration of two novel acetyl met-enkephalin analogues were evaluated compared to met-enkephalin.
Methods and Results: To permit the intrathecal administration of drugs into the lumbar subarachnoid space in adult Wistar rats, polyethylene (PE10) catheters were implanted in the L2 and L3 spinal segments in anesthetized animals. After a recovery time of 4-5 days, to protect the drugs from biodegradation, all rats were pretreated with peptidase inhibitors (APC) including Amastatin (A), Phosphoramidon (P) and captopril (C). Animals were dosed with intrathecal infusion of the analogues followed by tail flick latency test for an hour. Acetyl-Met-enk-CHO and Acetyl-Met-enk did not show significant antinociceptive effects in 10 nM (10-8 M) concentration. However Acetyl-Met-enk-CHO described discernible effects in 100 nm (10-7 M) in comparison with enkephalin. To estimate resistance against peptidase, molecular modeling was performed and showed compound Acetyl-Met-enk-CHO has low affinity to active site of aminopeptidase, dipeptidylcarboxypeptidase-I and neutral endopeptidase; the degrading endogenous enkephalin opioid peptides.
Conclusions: According to our results, Acethyl-Met-enk-CHO may provide comparable analgesic effects with, although with 10 folds less potency. With likely resistance against endogenous peptidase, this molecule could be a valuable lead compound for further studies
Antinociceptive effects of acetyl Leu-enkephalin derivatives following intrathecal administration in rat
Introduction: Intrathecal infusion of some enkephalin derivatives has been shown to restore analgesia in morphine tolerant patients with less adverse effects such as respiratory depression and constipation compared to morphine. Therefore developing new enkephalin derivatives is of central interest in pain management. In this study, antinociceptive effects of intrathecal administration of two novel acetyl met-enkephalin analogues were evaluated compared to met-enkephalin.
Methods and Results: To permit the intrathecal administration of drugs into the lumbar subarachnoid space in adult wistar rats, polyethylene (PE10) catheters were implanted in the L2 and L3 spinal segments in anesthetized animals. After a recovery time of 4-5 days, to protect the drugs from biodegradation, all rats were pretreated with peptidase inhibitors (APC) including Amastatin, Phosphoramidon and captopril. Animals were dosed with intrathecal infusion of the analogues followed by tail flick latency test for an hour. Acetyl-Leu-enk-CHO and Acetyl-Leu-enk did not show any significant antinociceptive effects in 10 nM (10-8 M) concentration. However Acetyl-Leu-enk demonstrated considerable effects in 100 nm (10-7 M) compared to Leu-enkephalin. Surprisingly, Acetyl-Met-Leu-enk-CHO antinociception did not improve but decreased with increasing intrathecal dosage to 100 nm, probably working as a partial agonist on opioid receptors.
Conclusions: According to our results, Acetyl-Leu-enk may provide better analgesic effects, compared to Acetyl-Leu-enk-CHO. With likely reverse dose-response effects on tail flick test, Acetyl-Leu-enk-CHO might be considered as a particular ligand for opioid receptors without full agonistic effect for further studies
Monomethyl Auristatin E, a Potent Cytotoxic Payload for Development of Antibody-Drug Conjugates against Breast Cancer
Background: Breast cancer is a heterogeneous disease characterized by differential responses to targeted and chemotherapeutic agents. Antibody-drug conjugates are one of the promising strategies for the treatment of breast cancer. Monomethyl auristatin E (MMAE) is a highly potent microtubule inhibitor and a common payload used for development of antibody-drug conjugates. The purpose of this study was to investigate the cytotoxic effects of MMAE on breast cancer cell lines.Materials and Methods: MDA-MB-468 and MDA-MB-453 cells were treated with MMAE at various concentrations (1, 10, 100, and 1000 ng/ml), and cytotoxicity was measured after 48 and 72 hours using an MTT assay.Results: Our findings indicated that MMAE possesses dose- and time-dependent cytotoxic activities against human breast cancer cells. The morphological features of the treated cells were supportive of the cytotoxic activity of MMAE. The results of the MTT assay showed that MMAE has a significant cytotoxicity against MDA-MB-468 and, to a lesser degree, MDA-MB-453 cells.Conclusion: MMAE can be used as a highly cytotoxic payload for development of antibody-drug conjugates against breast cancer
Monomethyl auristatin E Exhibits Potent Cytotoxic Activity against Human Cancer Cell Lines SKBR3 and HEK293
Background: Monomethyl auristatin E (MMAE) is a synthetic analog of dolastatin 10, a compound originally isolated from the marine mollusk. MMAE, as a highly potent microtubule inhibitor, exerts its potent cytotoxic effect by inhibiting microtubule assembly, tubulin-dependent GTP hydrolysis and microtubes polymerization. This molecule, by itself, lacks the tumor specificity required to elicit therapeutic benefit. Nevertheless, the extremely cytotoxic potential of MMAE could be harnessed in the form of MMAE-antibody conjugates. The aim of the present study was to evaluate the cytotoxic activity of MMAE against breast (SKBR3) and kidney (HEK293) cancer cell lines in an in vitro cell-based assay.Materials and Methods: SKBR3 and HEK293 cells were treated with different concentrations ranging from 0.002048, 0.01024, 0.0512, 0.256, 1.28, 6.4, 32, 160, 800 and 4000 nM of MMAE, and cell viability was determined after 72 hours using an MTT colorimetric assay. The effect of MMAE was regularly monitored by direct observation using an invert microscope.Results: Microscopic observation showed that there was a concentration-dependent increase in cell death. Results from the MTT assay revealed a statistically significant loss of viability (P<0.0001) at concentrations ranging from 0.01024 to 4000 nM in SKBR3 cells, and 0.0512 to 4000 nM in HEK293 cells. Our findings showed that MMAE inhibited the growth of SKBR3 and HEK293 cells in a concentration-dependent manner, with IC50 values of 3.27 ± 0.42 and 4.24 ± 0.37 nM, respectively.Conclusion: MMAE was able to significantly inhibit cell growth at nanomolar concentrations, emphasizing its great potential for the development of antibody-drug conjugates
Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application
Synthesis of triazones in aqueous media under microwave irradiation
612-613Three
component condensation of N,N'-dimethylurea, aqueous formaldehyde and
primary amines under microwave irradiation leads to triazones 4 in high yields.
 
A New and Efficient Method for the Synthesis of Pyrimido[2,1-b]benzothiazole Derivatives
ABSTRACT The one-pot three-component reaction of 2-aminobenzothiazole, benzaldehyde derivatives and β-ketoester, β-diketone or malonate derivatives in solvent-free conditions provides the corresponding pyrimido[2,1-b]benzothiazole derivatives at 60˚C in 60% -72% yields without using any catalyst in an optimistic time
Solid state deoximation with zinc chlorochromate: Regeneration of carbonyl compounds
1251-1252Aldoximes and ketoximes are oxidized with zinc chlorochromate in solvent-free conditions at room temperature to afford the corresponding carbonyl compounds
N-[2-(N-Cyclohexylcarbamoyl)propan-2-yl]-N-(2-iodophenyl)prop-2-ynamide
In the title compound, C19H23IN2O2, the cyclohexane ring adopts a chair conformation, and the mean plane of the propiolamide unit is approximately perpendicular to the benzene ring [dihedral angle = 88.12&#8197;(13)&#176;]. Weak intramolecular C&#8212;H...O hydrogen bonding is observed between the carbonyl group and the benzene ring. In the crystal, classical N&#8212;H...O hydrogen bonds and weak C&#8212;H...O interactions are present
- …